Limin Liu

Limin Liu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2022 in Translational Oncology
Verified
Journal Article
Open access
JHJinmei Huang
Jinmei Huang
MZMing Zhou
Ming Zhou
HZHuan Zhang
Huan Zhang
YFYeying Fang
Yeying Fang
GCGang Chen
Gang Chen
LLLimin Liu
Limin Liu
• Scutellaria baicalensis has reversal effect on radio-resistance of colorectal cancer (CRC). • Wogonin is the main active component of Scutellaria baicalensis. • SULT2B1 is highly expressed in CRC and associated with poor prognosis. • Wogonin could increase the radio-resistance sensitivity of CRC. • Wogonin reverses radio-resistance in CRC by targeting SULT2B1.

1 February 2021 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
HLHong-Chang Li
Hong-Chang Li
QXQing-Min Xu
Qing-Min Xu
LLLimin Liu
Limin Liu
LWLin-Hua Wu
Lin-Hua Wu
ZTZi-Tian Tang
Zi-Tian Tang
YLYan-cheng Liu
Yan-cheng Liu

14 January 2026 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
YHYun-Hou Huang
Yun-Hou Huang
YLYuan Liu
Yuan Liu
YHYue Huang
Yue Huang
WMWei-Ying Meng
Wei-Ying Meng
HWHong-Zu Wei
Hong-Zu Wei
YLYan-cheng Liu
Yan-cheng Liu

24 August 2026 in Hereditas
Verified
Journal Article
Open access
PDF file
HLHui Li
Hui Li
RLRui Lin
Rui Lin
KWKe-Jun Wu
Ke-Jun Wu
JLJin-Cheng Li
Jin-Cheng Li
LWLong Wei
Long Wei
SZSen Zhang
Sen Zhang
Colorectal cancer (CRC) remains a leading cause of cancer mortality with few effective targeted therapies. Kinesin family member 11 (KIF11), a motor protein essential for mitotic spindle assembly, is frequently overexpressed in multiple cancers. We hypothesized that nitidine chloride (NC), a natural benzophenanthridine alkaloid with documented anti-tumor activity, might suppress CRC by targeting KIF11.Molecular docking predicted a strong interaction between NC and KIF11 (− 9.0 kcal/mol). RNA sequencing, quantitative RT-PCR, and immunohistochemistry confirmed that NC treatment markedly downregulated KIF11 expression. Meta-analysis across public datasets showed consistent KIF11 mRNA overexpression in CRC (standardized mean difference [SMD] = 1.33; AUC = 0.87), while in-house immunohistochemistry on 416 clinical specimens demonstrated even stronger protein-level elevation (AUC = 0.99) that correlated with larger tumor size and deeper invasion. Single-cell RNA sequencing and spatial transcriptomics further revealed that KIF11 is preferentially expressed in proliferative malignant epithelial cells. Through CRISPR-based knockout screening and lentiviral silencing, KIF11 depletion impaired the growth or viability of the examined CRC cell models. Public ChIP-seq data suggested RAD21 occupancy near the KIF11 regulatory region, whereas reciprocal co-immunoprecipitation supported an association between the RAD21 and KIF11 proteins. Among genes co-expressed with KIF11,a pronounced enrichment was observed in pathways governing cell-cycle progression. Following KIF11 knockdown, transcriptomic profiling showed reduced expression across cell-cycle, DNA-replication, and chromatin-cohesion programs, alongside a reciprocal increase in amino-acid metabolism and stress-response genes. At the functional level, KIF11 depletion suppressed cell proliferation and induced G2/M-phase arrest. Taken together, these in vitro and limited xenograft data indicate that NC restrains CRC growth chiefly through the RAD21–KIF11 axis; KIF11 represents a promising preclinical target, though comprehensive systematic in vivo pharmacodynamic and translational animal validation remains absent in the current study and requires further independent investigation.

12 May 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
XHXiao-Jue Huang
Xiao-Jue Huang
LMLiu-Hui Mo
Liu-Hui Mo
KWKe-Jun Wu
Ke-Jun Wu
RHRong-Quan He
Rong-Quan He
HLHui Li
Hui Li
LLLimin Liu
Limin Liu
Background: Colorectal cancer (CRC) remains a major global health burden. While nitidine chloride (NC) exhibits anti-tumor effects, its molecular targets in CRC are still largely unknown. Methods: To delineate the role of Polo-like kinase 1 (PLK1) in CRC, we combined RNA sequencing with comprehensive multi-omics integration across 3,513 specimens (2,256 tumor and 1,257 non-tumor). Single-cell and spatial transcriptomic approaches were employed to map PLK1 expression heterogeneity and its precise localization within tumor architecture. Direct interaction between NC and PLK1 was evaluated through 100-ns GROMACS molecular dynamics simulations of the PLK1 structure retrieved from the Protein Data Bank structures and MM-PBSA binding free energy analysis. Upstream regulation by MYCN was probed via public ChIP-seq datasets, E-box motif scanning, and AlphaFold-Multimer docking. Functional validation included RT-qPCR quantification of PLK1 mRNA in NC-treated HCT116 cells and dose-dependent IHC analysis of PLK1 protein in HCT116 xenograft tumors following NC or 5-FU administration. Results: PLK1 was identified as a prominent NC-responsive gene and was consistently overexpressed in CRC across multiple datasets. Enrichment analyses indicated that PLK1-associated genes were mainly involved in cell cycle-related pathways. Molecular dynamics simulations supported a stable interaction pattern between NC and PLK1. Single-cell and spatial transcriptomic analyses showed that PLK1 expression was enriched in malignant epithelial cells and proliferative tumor regions and displayed marked intratumoral heterogeneity. NC treatment significantly reduced PLK1 expression at both the mRNA and protein levels. In addition, MYCN was concurrently downregulated after NC treatment, and integrated public-cohort analyses showed that MYCN was positively correlated with PLK1 expression in CRC. Combined with genome browser visualization, motif analysis, and structural modeling, these findings suggest a potential association between MYCN and PLK1 regulatory activity. Conclusions: This study identifies PLK1 as an important candidate target of NC in CRC and demonstrates that NC suppresses PLK1 expression at both the transcript and protein levels. Integrative analyses further indicate that the MYCN–PLK1 axis may represent a potential regulatory component associated with the anti-CRC effects of NC. Nitidine chloride; Polo-like kinase 1; MYCN; Molecular dynamics simulation; Multi-omics; Spatial transcriptomics; Colorectal cancer.

15 April 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
XLXuanbao Lian
Xuanbao Lian
JLJun Luo
Jun Luo
LWLizhi Wei
Lizhi Wei
HZHongliang Zhang
Hongliang Zhang
YCYiyu Chen
Yiyu Chen
KWKunxuan Wei
Kunxuan Wei
Antimicrobial Stewardship Pharmacy Consultation (ASPC) in China has been shown to reduce patients' length of stay (LOS). However, prolonged LOS remains a challenge, resulting in unnecessary psychological and financial burden for patients. This study aimed to develop a prediction model using ASPC parameters to identify high-risk pediatric patients with infectious diseases. These patients received ASPC interventions but still experienced prolonged LOS, which defined their high-risk status. Predictors for the ASPC model were selected using lasso regression, a nomogram was developed using multivariate logistic regression, and internal validation was performed using tenfold cross-validation. The data set consisted of 474 electronic medical records of pediatric patients with infectious diseases from two hospitals. LOS was dichotomized at the median, and patients with LOS greater than the median were considered to have achieved the outcome. The proportion of outcome events was set at 50% by design. Five independent predictors were identified in the ASPC model: (1) the suggestions from the crucial consultation (OR: 1.74; 95% CI: 1.10 to 2.74), (2) weight (OR: 0.98; 95% CI: 0.97 to 1.00), (3) whether the patient received first aid (OR: 0.54; 95% CI: 0.3 to 1.00), (4) the aim of the crucial consultation (OR: 0.15; 95% CI: 0.03 to 0.66), and (5) whether the patient was critically ill (OR: 0.22; 95% CI: 0.12 to 0.41). The ASPC model showed good discrimination with a C-statistic of 0.772 (95% CI: 0.748 to 0.797) and good calibration performance with intercept and slope values of 0.00 (95% CI: -0.12 to 0.12) and 0.93 (95% CI: 0.82 to 1.04), respectively, under tenfold cross-validation. The antimicrobial stewardship pharmacy consultation model has good discrimination and calibration, and effectively identifies patients at risk for prolonged length of stay. Extensive research on clinical pharmacy practice has highlighted the important role that clinical pharmacists play in patient care and their valuable contributions to personalized medical treatment. However, the quality of pharmacy consultations in China still requires improvement to gain wider recognition from clinicians. Our study examined the impact of Antimicrobial Stewardship Pharmacy Consultations (ASPCs) on the length of stay (LOS) among pediatric patients with infectious diseases and developed a risk prediction model to identify the high-risk patients who received ASPC interventions yet still experienced prolonged LOS. This model has the potential to enhance the quality of ASPC, reduce patients' psychological and financial burdens, and support the advancement of clinical pharmacy practice in China.